Delivery Order 75N93022D00018-75N93022F00001
- This is a cost-plus-fixed-fee delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Icon Government And Public Health Solutions, Inc. The $102,610.29 order supports NIAID's Phase 1 Clinical Trial Unit for Therapeutics Against Infectious Diseases program, which conducts early-stage clinical trials of investigational products. The contract is part of a larger $545 million NIAID...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a delivery order valued at $2.054 million to Icon Government and Public Health Solutions, Inc. on September 30, 2024, for performance through September 29, 2028. This contract, designated NIAID CARRRP A2024-2 - VRC 020, is issued under the Comprehensive and Rapid Response to NIAID Research Programs Indefinite Delivery/Indefinite Quantity (IDIQ) contract and will be performed in Rockville, Maryland. The award utilizes a...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to ICON Government and Public Health Solutions, Inc., a foreign-owned, for-profit organization. The contract is for a Phase 1 Clinical Trial Unit to support the development of therapeutics against infectious diseases. The contract is a Cost Plus Fixed Fee Delivery Order with a ceiling value of $36,748.58 and a completion date of December 14, 2020. The contract is not...
- Icon Government and Public Health Solutions, Inc. was awarded a $119,681 delivery order against the Therapeutics Against Infectious Diseases Phase 1 master indefinite delivery/indefinite quantity contract held with the National Institutes of Health National Institute of Allergy and Infectious Diseases. This delivery order, with a potential value of $48,905.35 and period of performance through February 2024, provides for a Phase 1 Clinical Trial Unit for Therapeutics Against Infectious Diseases...
- This is a delivery order awarded by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to Icon Government And Public Health Solutions, Inc. The order, valued at $203,215, is for the contractor to provide clinical research management and conduct a Phase 1 clinical trial unit to evaluate therapeutics against infectious diseases. This order is part of a larger 5-year indefinite delivery/indefinite quantity contract...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Icon Government And Public Health Solutions, Inc., a foreign-owned, for-profit organization. The contract is a Delivery Order under the Early Phase Clinical Trial Units (EPCTU) Indefinite Delivery Vehicle (IDV) contract, with a ceiling value of $2,021,154.00. The scope of work includes activities defined in the IDIQ contract for Task Area C: Phase I Healthy Volunteer...
- This is a delivery order awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Icon Government And Public Health Solutions, Inc. for a Phase I clinical trial unit to support development of therapeutics against infectious diseases. The contract has a potential value of $117,402.00 and is a Cost Plus Fixed Fee contract type. Icon Government And Public Health Solutions, Inc. is a global provider of outsourced...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $2.51 million cost-plus-fixed-fee delivery order to Icon Government and Public Health Solutions, Inc. on January 14, 2022, for a Phase 1 clinical trial evaluating an orally ingested genetically modified probiotic yeast designed to express a tetra-specific anti-toxin for Clostridioides difficile infection. The award, issued without a set-aside designation, is structured as a delivery order under the Early Phase Clinical...
- This contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Icon Government And Public Health Solutions, Inc., a for-profit organization. The $113,678.00 contract is a delivery order under the "Therapeutics Against Infectious Diseases Phase 1" indefinite delivery/indefinite quantity (IDIQ) contract vehicle, which enables streamlined ordering of clinical trial and...
- This federal contract award is for a $214,395 task order issued under the National Institute of Allergy and Infectious Diseases' (NIAID) "Therapeutics Against Infectious Diseases Phase 1" contract vehicle. The task order is for a Phase 1 clinical trial unit to support the development of therapeutics against infectious diseases. The prime contractor, Icon Government And Public Health Solutions, Inc., is a foreign-owned, for-profit organization that specializes in providing comprehensive...
- Early Phase Clinical Trial Units (EPCTU)Master IDIQ
- 75N93022D00018Indefinite Delivery Contract
- 75N93022D00018-75N93022F00001Delivery Order
The National Institute of Allergy and Infectious Diseases (NIAID) issued Task Order 75N93022F00001 to Icon Government and Public Health Solutions, Inc., a clinical research services contractor specializing in medical countermeasure development and infectious disease research. This cost-plus-fixed-fee delivery order, awarded on January 14, 2022, carries a ceiling value of $1.6 million and is scheduled for completion by January 13, 2032. The task order was issued under the Early Phase Clinical Trial Units (EPCTU) indefinite delivery vehicle, a $346.6 million IDIQ contract that enables NIAID to rapidly procure clinical trial services across multiple programs. No set-aside designation was applied to this award, indicating open competition. Work will be performed in Hinckley, Ohio. Icon Government and Public Health Solutions, Inc., headquartered in Blue Bell, Pennsylvania, brings extensive experience executing federally funded clinical research initiatives, including notable COVID-19 vaccine trials and investigational infectious disease product evaluations. The contractor's track record includes numerous substantial contract awards from HHS, NIH, NIAID, the Office of the Assistant Secretary for Preparedness and Response, and the Department of Defense, covering protocol development, study execution, regulatory submissions, and participant recruitment. This task order supports NIAID's mission to conduct and support research on allergic and immunologic diseases, with particular focus on infectious disease countermeasures and public health emergency preparedness.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Exercise an Option | $161.3k | 1/14/26 | |
| P00003 | Exercise an Option | $160.1k | 1/13/25 | |
| P00002 | Exercise an Option | $164.1k | 1/11/24 | |
| P00001 | Exercise an Option | $157.7k | 1/9/23 | |
| Not listed | Not listed | $160.8k | 1/21/22 |